Novavax, Inc. (NasdaqGS:NVAX) Valued at 833756

Investors are constantly examining different company financial indicators to assess trading opportunities. Novavax, Inc. (NasdaqGS:NVAX) presently has an EV or Enterprise Value of 833756. The EV is used to show how the market assigns value to a company as a whole. EV is basically a modification of market cap, as it incorporates debt and cash for assessing a firm’s valuation. Tracking EV may help when comparing companies with different capital structures. EV can help investors gain a truer sense of whether a company is undervalued or not.Making the grade in the equity market may not come easily. There is constantly news and information swirling about the next big stock that is ready to take off. Doing a deep-dive into the fundamentals of a specific company may help uncover some data that may help sway the decision whether to jump in or stay out. Some investors may choose to take a contrarian approach when selecting stocks. A contrarian investing strategy may involve buying when everybody is selling, or vice-versa. Contrarians may take the mindset that markets have the ability to overreact to good news or bad news. Going against the grain may not be the easiest strategy to adapt for the novice. Investors may need to fine tune their skills in order to go generally against the crowd. There may come a time when everyone may be selling out of a stock for no real apparent reason. Taking a closer look at stocks like this may reveal some information that may help put the mind at ease.Currently, Novavax, Inc. (NasdaqGS:NVAX)’s ROIC is -2.205435. The ROIC 5 year average is -1.407395 and the ROIC Quality ratio is -3.690048. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a company is at turning capital into profits. ROIC may be a good measure to view when examining whether or not a company is able to invest wisely. ROIC may also be an important metric for the value investor who is trying to determine the company’s moat. Novavax, Inc. (NasdaqGS:NVAX) has a current Value Composite Score of 99. Using a scale from 0 to 100, a lower score would represent an undervalued company and a higher score would indicate an expensive or overvalued company. This ranking was developed by James O’Shaughnessy using six different valuation ratios including price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings, and shareholder yield.Investors seeking value in the stock market may be eyeing the Magic Formula Rank or MF Rank for Novavax, Inc. (NasdaqGS:NVAX). Presently, the company has a MF Rank of 17516. The Magic Formula was devised and made popular by Joel Greenblatt in his book “The Little Book That Beats the Market”. Greenblatt’s formula helps find stocks that are priced attractively with a high earnings yield, or strong reported profits in comparison to the market value of the company. To spot opportunities in the market, investors may be searching for stocks that have the lowest combined MF Rank.Market watchers may also be following some quality ratios for Novavax, Inc. (NasdaqGS:NVAX). Currently, the company has a Gross Margin (Marx) ratio of -0.482803. This calculation is based on the research by University of Rochester professor Robert Novy-Marx. Marx believed that a high gross income ratio was a sign of a quality company. Looking further, Novavax, Inc. (NasdaqGS:NVAX) has a Gross Margin score of 4.00000. This score is based on the Gross Margin (Marx) metric using a scale from 1 to 100 where a 1 would be seen as positive, and a 100 would be viewed as negative.Many individual investors would agree that self confidence can play a major role when investing in the stock market. Learning how to trust instinct might be the difference between a good trade and a great trade. Investors who are able to develop a high level of self confidence may be able to pull the handle on a trade that most other people wouldn’t. Of course this may work against the investor who pushes self confidence into over confidence territory. Investors may also have to master the art of being patient in the stock market. Often times there are strategies that take time to fully develop. Taking the time to make solid investing decisions can mean the difference between realized profits and portfolio busters.The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Novavax, Inc. (NasdaqGS:NVAX) for last month was 0.95783. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Novavax, Inc. (NasdaqGS:NVAX) is 1.44545.VolatilityStock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Novavax, Inc. (NasdaqGS:NVAX) is 73.521500.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of Novavax, Inc. (NasdaqGS:NVAX) is 56.685400.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 104.265000.Investors are always striving to locate the next great stock to add to the portfolio. Finding that next winner may involve some dedicated research and perseverance. Sorting through the immense amount of information about public companies can be a chore. Many sharp investors will attack the equity markets from many various angles. This may encompass keeping close tabs on fundamental and technical data. This may also include monitoring analyst opinions and tracking institutional transactions.Price Range 52 WeeksSome of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. The Price Range of Novavax, Inc. (NasdaqGS:NVAX) over the past 52 weeks is 0.657000. The 52-week range can be found in the stock’s quote summary.The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Novavax, Inc. (NasdaqGS:NVAX) is 0.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.Investors may be doing a mid-year review of the portfolio. They may be looking to see what changes need to be made for the second half of the year. Maybe there were some great performers that don’t need much attention. There may also be some not so great performers that need to be looked at a little bit closer. As the next earnings reports become available, investors will be able to scrutinize the numbers. Investors may be tracking sell-side analyst projections heading into earnings. Analysts will often update their numbers as the earnings date approaches.

Investors are constantly examining different company financial indicators to assess trading opportunities. Novavax, Inc. (NasdaqGS:NVAX) presently has an EV or Enterprise Value of 833756. The EV is used to show how the market assigns value to a company as a whole. EV is basically a modification of market cap, as it incorporates debt and cash for assessing a firm’s valuation. Tracking EV may help when comparing companies with different capital structures. EV can help investors gain a truer sense of whether a company is undervalued or not.

Making the grade in the equity market may not come easily. There is constantly news and information swirling about the next big stock that is ready to take off. Doing a deep-dive into the fundamentals of a specific company may help uncover some data that may help sway the decision whether to jump in or stay out. Some investors may choose to take a contrarian approach when selecting stocks. A contrarian investing strategy may involve buying when everybody is selling, or vice-versa. Contrarians may take the mindset that markets have the ability to overreact to good news or bad news. Going against the grain may not be the easiest strategy to adapt for the novice. Investors may need to fine tune their skills in order to go generally against the crowd. There may come a time when everyone may be selling out of a stock for no real apparent reason. Taking a closer look at stocks like this may reveal some information that may help put the mind at ease.

Currently, Novavax, Inc. (NasdaqGS:NVAX)’s ROIC is -2.205435. The ROIC 5 year average is -1.407395 and the ROIC Quality ratio is -3.690048. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a company is at turning capital into profits. ROIC may be a good measure to view when examining whether or not a company is able to invest wisely. ROIC may also be an important metric for the value investor who is trying to determine the company’s moat. Novavax, Inc. (NasdaqGS:NVAX) has a current Value Composite Score of 99. Using a scale from 0 to 100, a lower score would represent an undervalued company and a higher score would indicate an expensive or overvalued company. This ranking was developed by James O’Shaughnessy using six different valuation ratios including price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings, and shareholder yield.

Investors seeking value in the stock market may be eyeing the Magic Formula Rank or MF Rank for Novavax, Inc. (NasdaqGS:NVAX). Presently, the company has a MF Rank of 17516. The Magic Formula was devised and made popular by Joel Greenblatt in his book “The Little Book That Beats the Market”. Greenblatt’s formula helps find stocks that are priced attractively with a high earnings yield, or strong reported profits in comparison to the market value of the company. To spot opportunities in the market, investors may be searching for stocks that have the lowest combined MF Rank. 

Market watchers may also be following some quality ratios for Novavax, Inc. (NasdaqGS:NVAX). Currently, the company has a Gross Margin (Marx) ratio of -0.482803. This calculation is based on the research by University of Rochester professor Robert Novy-Marx. Marx believed that a high gross income ratio was a sign of a quality company. Looking further, Novavax, Inc. (NasdaqGS:NVAX) has a Gross Margin score of 4.00000. This score is based on the Gross Margin (Marx) metric using a scale from 1 to 100 where a 1 would be seen as positive, and a 100 would be viewed as negative.

Many individual investors would agree that self confidence can play a major role when investing in the stock market. Learning how to trust instinct might be the difference between a good trade and a great trade. Investors who are able to develop a high level of self confidence may be able to pull the handle on a trade that most other people wouldn’t. Of course this may work against the investor who pushes self confidence into over confidence territory. Investors may also have to master the art of being patient in the stock market. Often times there are strategies that take time to fully develop. Taking the time to make solid investing decisions can mean the difference between realized profits and portfolio busters.

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Novavax, Inc. (NasdaqGS:NVAX) for last month was 0.95783. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Novavax, Inc. (NasdaqGS:NVAX) is 1.44545.

Volatility

Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Novavax, Inc. (NasdaqGS:NVAX) is 73.521500.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of Novavax, Inc. (NasdaqGS:NVAX) is 56.685400.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 104.265000.

Investors are always striving to locate the next great stock to add to the portfolio. Finding that next winner may involve some dedicated research and perseverance. Sorting through the immense amount of information about public companies can be a chore. Many sharp investors will attack the equity markets from many various angles. This may encompass keeping close tabs on fundamental and technical data. This may also include monitoring analyst opinions and tracking institutional transactions.

Price Range 52 Weeks

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. The Price Range of Novavax, Inc. (NasdaqGS:NVAX) over the past 52 weeks is 0.657000. The 52-week range can be found in the stock’s quote summary.

The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Novavax, Inc. (NasdaqGS:NVAX) is 0.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.

Investors may be doing a mid-year review of the portfolio. They may be looking to see what changes need to be made for the second half of the year. Maybe there were some great performers that don’t need much attention. There may also be some not so great performers that need to be looked at a little bit closer. As the next earnings reports become available, investors will be able to scrutinize the numbers. Investors may be tracking sell-side analyst projections heading into earnings. Analysts will often update their numbers as the earnings date approaches.

Leave a Reply

Your email address will not be published. Required fields are marked *